share_log

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

Businesswire ·  Jan 2 19:00

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.



  • J.P. Morgan Healthcare Conference, San Francisco
    Presentation followed by Q&A on Monday, January 13, 2025 at 1:30 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at .

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard and Oncotype tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.


Contacts

Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment